These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35258491)
1. Expression of IL-37 Correlates With Immune Cell Infiltrate and Fibrosis in Pediatric Autoimmune Liver Diseases. Griessmair L; Pirringer L; Mountford S; Sendelhofert A; Makeschin MC; Koletzko S; Mayr D; Bufler P J Pediatr Gastroenterol Nutr; 2022 Jun; 74(6):742-749. PubMed ID: 35258491 [TBL] [Abstract][Full Text] [Related]
2. The role of complement activation in autoimmune liver disease. Biewenga M; Farina Sarasqueta A; Tushuizen ME; de Jonge-Muller ESM; van Hoek B; Trouw LA Autoimmun Rev; 2020 Jun; 19(6):102534. PubMed ID: 32234403 [TBL] [Abstract][Full Text] [Related]
3. Biliary features in liver histology of children with autoimmune liver disease. Di Giorgio A; D'Adda A; Marseglia A; Sonzogni A; Licini L; Nicastro E; D'Antiga L Hepatol Int; 2019 Jul; 13(4):510-518. PubMed ID: 31069759 [TBL] [Abstract][Full Text] [Related]
4. Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in mice. Hintermann E; Bayer M; Conti CB; Fuchs S; Fausther M; Leung PS; Aurrand-Lions M; Taubert R; Pfeilschifter JM; Friedrich-Rust M; Schuppan D; Dranoff JA; Gershwin ME; Manns MP; Imhof BA; Christen U J Autoimmun; 2018 Jul; 91():83-96. PubMed ID: 29753567 [TBL] [Abstract][Full Text] [Related]
5. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Deneau M; Jensen MK; Holmen J; Williams MS; Book LS; Guthery SL Hepatology; 2013 Oct; 58(4):1392-400. PubMed ID: 23686586 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6. Hintermann E; Ehser J; Bayer M; Pfeilschifter JM; Christen U J Autoimmun; 2013 Aug; 44():49-60. PubMed ID: 23809878 [TBL] [Abstract][Full Text] [Related]
8. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood. Maggiore G; Riva S; Sciveres M Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308 [TBL] [Abstract][Full Text] [Related]
9. Evolving Practice and Changing Phenotype in Pediatric Autoimmune Liver Disease: Outcomes From an Australian Center. Singh H; Balouch F; Noble C; Lewindon P J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):80-85. PubMed ID: 29470284 [TBL] [Abstract][Full Text] [Related]
18. Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease. Richardson N; Wootton GE; Bozward AG; Oo YH Semin Immunopathol; 2022 Jul; 44(4):461-474. PubMed ID: 35641679 [TBL] [Abstract][Full Text] [Related]
19. Effects of adenovirus-induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse model. Fuchs S; Bayer M; Taubert R; Manns MP; Pfeilschifter JM; Christen U; Hintermann E Liver Int; 2019 Dec; 39(12):2330-2340. PubMed ID: 31225929 [TBL] [Abstract][Full Text] [Related]
20. Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Rα(-/-) mice. Yao Y; Yang W; Yang YQ; Ma HD; Lu FT; Li L; Tao YY; Tsuneyama K; Zhang W; Friedman S; Gershwin ME; Lian ZX J Autoimmun; 2014 Jun; 51():99-108. PubMed ID: 24651036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]